Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn how well a study drug patch on the skin works and how safe it is compared with a placebo patch as a possible treatment for peanut allergy.
Children 4 to 7 years old who have been diagnosed with a peanut allergy may be eligible to participate.
The study includes 12 study visits over about 58 weeks. Here are some of the things that will happen in this study.
Your child will be randomly assigned (like flipping a coin) to receive either the DBV712 patch (study drug patch) or the placebo patch which does not have any active study drug. Both patches will look the same and be placed in the same area of your child’s back.
You will:
Your child will:
Prior to the start of the study, you will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and answer your questions.
Your child may or may not benefit from being part of this research study. The study drug patch may help with your child’s peanut allergy symptoms, increasing how much they can ingest prior to occurrence of an allergic reaction, but there is no guarantee that it will. The information we learn from this study may help other children with peanut allergy in the future.
Your child could have an allergic reaction during the food challenges. We will discuss this risk and other risks and discomforts with you prior to the start of the study.
Participants will receive up to $1,575 for time and effort.
Glenda Knox
513-636-2733
glenda.knox@cchmc.org
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Amal Assa’ad, MD
Allergy and Immunology
Cincinnati Children’s Hospital Medical Center